OM

Opaleye Management Portfolio holdings

AUM $494M
1-Year Est. Return 68.17%
This Quarter Est. Return
1 Year Est. Return
+68.17%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$495M
AUM Growth
+$118M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
59
New
Increased
Reduced
Closed

Top Buys

1
+$13.9M
2
+$10.3M
3
+$8.78M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$8.36M
5
OCUL icon
Ocular Therapeutix
OCUL
+$7.18M

Top Sells

1
+$36.8M
2
+$5.63M
3
+$4.83M
4
ZYME icon
Zymeworks
ZYME
+$4.72M
5
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
+$4.66M

Sector Composition

1 Healthcare 91.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$6.83M 1.38%
33,000
-2,560
27
$6.55M 1.32%
238,300
+44,300
28
$6.53M 1.32%
+2,105,000
29
$6.43M 1.3%
+77,800
30
$5.69M 1.15%
5,840
31
$5.58M 1.13%
461,500
+236,500
32
$5.34M 1.08%
1,155,000
+105,000
33
$4.98M 1.01%
+5,875
34
$4.65M 0.94%
1,878,500
-315,000
35
$3.79M 0.77%
7,227
-8,429
36
$3.58M 0.72%
48,533
+3,230
37
$3.37M 0.68%
+400,000
38
$3.26M 0.66%
+471,600
39
$3.24M 0.65%
250,000
+169,000
40
$3.15M 0.64%
22,750
41
$2.96M 0.6%
+590,000
42
$2.46M 0.5%
+960,000
43
$1.43M 0.29%
+171,000
44
$1.08M 0.22%
+175,000
45
$962K 0.19%
+60,000
46
$754K 0.15%
+220,000
47
$385K 0.08%
3,202
-23,968
48
$29K 0.01%
417
49
– –
-1,500
50
– –
-56,263
1
2
3